Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection (Q39955190)

15 September 2017

Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection (English)

1 reference

15 September 2017

1 reference

Cryptococcus neoformans

1 reference

Francesco Barchiesi

1

1 reference

15 September 2017

Elisabetta Spreghini

2

1 reference

15 September 2017

Anna M Schimizzi

3

1 reference

15 September 2017

Monia Maracci

4

1 reference

15 September 2017

Daniele Giannini

5

1 reference

15 September 2017

Flavia Carle

6

1 reference

15 September 2017

Giorgio Scalise

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

48

1 reference

15 September 2017

9

1 reference

15 September 2017

3312-3316

1 reference

Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Interactions of posaconazole and flucytosine against Cryptococcus neoformans

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Interactions between triazoles and amphotericin B against Cryptococcus neoformans

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Update: trends in AIDS incidence, deaths, and prevalence--United States, 1996.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=514762

Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band Ketoconazole

20 August 2018

1 reference

12 December 2020

Treatment of Experimental Cryptococcal Meningitis with Amphotericin B, 5-Fluorocytosine, and Ketoconazole

1 reference

12 December 2020

Combination of Oral Flucytosine and Ketoconazole as Therapy for Experimental Cryptococcal Meningitis

1 reference

12 December 2020

Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis

1 reference

12 December 2020

Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis

1 reference

12 December 2020

Combination antifungal therapy

1 reference

12 December 2020

10.1128/AAC.48.9.3312-3316.2004

Identifiers

DOI

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

15328090

1 reference